Clinical Outcomes in Urologic Cancers
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 7609
Special Issue Editors
2. Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy
Interests: urologic oncology; bladder cancer; kidney cancer; prostate cancer; epidemiology
Special Issues, Collections and Topics in MDPI journals
Interests: urologic oncology; bladder cancer; kidney cancer; prostate cancer; epidemiology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are delighted to introduce this Special Issue dedicated to exploring the latest advancements and insights into the clinical outcomes of urological cancers. Urological malignancies encompass a diverse range of challenging conditions affecting the urinary system, and understanding their clinical outcomes is paramount to refining treatment strategies and improving patients’ care.
This Special Issue brings together a compendium of cutting-edge research, comprehensive reviews, and clinical studies that shed light on the evolving landscape of urological cancer management. We aim to delve into crucial outcome measures, such as survival rates, treatment responses, and quality-of-life assessments, to provide a holistic perspective of the efficacy and safety of current therapeutic approaches.
By collating the works of distinguished researchers and practitioners in this field, we aspire to foster a deeper understanding of the factors influencing clinical outcomes, identify areas for improvement, and pave the way for novel interventions. We sincerely hope that this collection of knowledge will empower clinicians worldwide to make informed decisions and enhance patient outcomes, ultimately bringing us closer to conquering urological cancers.
Dr. Simone Morra
Prof. Dr. Pierre Karakiewicz
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bladder cancer
- prostate cancer
- kidney cancer
- upper tract urothelial carcinoma
- adrenocortical cancer